- Home
- VTGN vs FOXX Comparison
VTGN vs FOXX Comparison
Compare VTGN & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VTGN | FOXX |
|---|---|---|
| Founded | 1998 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.8M | 34.0M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | VTGN | FOXX |
|---|---|---|
| Price | $0.61 | $3.80 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $0.90 | N/A |
| AVG Volume (30 Days) | ★ 736.7K | 10.7K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ N/A |
| Revenue This Year | $124.49 | N/A |
| Revenue Next Year | $353.99 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.43 | $1.71 |
| 52 Week High | $5.14 | $8.70 |
Technical Indicators
Market Signals| Indicator | VTGN | FOXX |
|---|---|---|
| Relative Strength Index (RSI) | 44.36 | 38.62 |
| Support Level | $0.50 | $3.80 |
| Resistance Level | $0.65 | $4.80 |
| Average True Range (ATR) | 0.04 | 0.37 |
| MACD | 0.02 | -0.12 |
| Stochastic Oscillator | 54.55 | 15.58 |
Price Performance
Historical ComparisonAbout VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
About FOXX Foxx Development Holdings Inc.
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.